Medical
About Us
Sustainability
We have posted data related to our ESG.
Item |
Unit |
FY2017 |
FY2018 |
FY2019 |
FY2020 |
FY2021 |
Scope |
---|---|---|---|---|---|---|---|
Greenhouse gas emissions Scope 1 |
t-CO₂ |
2,120 |
1,969 |
1,916 |
1,906 |
2,016 |
Eiken Group 1 |
Greenhouse gas emissions Scope 2 |
t-CO₂ |
5,252 |
5,299 |
5,001 |
5,173 |
5,302 | |
Greenhouse gas emissions Scope 1 and 2 |
t-CO₂ |
7,372 |
7,268 |
6,917 |
7,079 |
7,318 |
|
Greenhouse gas emissions Scope 3 2 Total | t-CO2 | ー | ー | ー | 86,485 | 105,334 | |
Cat.1 Purchased goods and services |
t-CO2 | ー | ー | ー | 50,206 | 55,450 | |
Cat.2 Capital goods | t-CO2 | ー | ー | ー | 5,383 | 3,385 | |
Cat.3 Fuel- and energy-related activities not included in scope 1 or scope 2 | t-CO2 | ー | ー | ー | 995 | 1,045 | |
Cat.4 Upstream transportation and distribution | t-CO2 | ー | ー | ー | 1,670 | 2,181 | |
Cat.5 Waste generated in operations | t-CO2 | ー | ー | ー | 53 | 59 | |
Cat.6 Business travel | t-CO2 | ー | ー | ー | 133 | 138 | |
Cat.7 Employee commuting | t-CO2 | ー | ー | ー | 696 | 624 | |
Cat.8 Upstream leased assets | t-CO2 | ー | ー | ー | Not relevant | Not relevant | |
Cat.9 Downstream transportation and distribution | t-CO2 | ー | ー | ー | 21,145 | 36,098 | |
Cat.10 Processing of sold products | t-CO2 | ー | ー | ー | Not relevant | Not relevant | |
Cat.11 Use of sold products | t-CO2 | ー | ー | ー | 2,549 | 1,895 | |
Cat.12 End-of-life treatment of sold products | t-CO2 | ー | ー | ー | 3,654 | 4,458 | |
Cat.13 Downstream leased assets | t-CO2 | ー | ー | ー | Not relevant | Not relevant | |
Cat.14 Franchises | t-CO2 | ー | ー | ー | Not relevant | Not relevant | |
Cat.15 Investments | t-CO2 | ー | ー | ー | Not relevant | Not relevant | |
Renewable-energy output |
kwh |
69,620 |
76,494 |
70,349 |
60,685 |
61,941 |
Eiken Chemical Co., Ltd. |
Water volume consumed |
1000cu.m |
88.1 |
83.9 |
81.0 |
78.0 |
80.6 |
Eiken Group (Production sites) |
Wastewater volume |
1000cu.m |
77.5 |
71.8 |
74.3 |
69.4 |
67.5 |
|
Energy consumption rate (crude-oil equivalent)3 |
kl |
2,978 |
2,954 |
2,921 |
2,988 |
3,326 |
Eiken Chemical Co., Ltd. |
Total waste emissions 4 |
t |
426 |
381 |
388 |
410 |
462 |
Eiken Group (Head Office/Production sites/Laboratories) |
Waste used for material recycling |
t |
251 |
212 |
234 |
223 |
232 |
|
Recycled waste (including energy recovery) |
t |
251 |
212 |
264 |
256 |
272 |
|
Recycling rate (including energy recovery) |
% |
58.9 |
55.7 |
68.1 |
62.4 |
58.8 |
|
Total amount of waste disposal 5 |
t |
177 |
169 |
124 |
154 |
170 |
|
Number of eco-proposals |
Proposals |
366 |
445 |
454 |
318 |
291 |
Eiken Chemical Co., Ltd. |
*GHG Scope1: Direct emission from own fuel usage or usage in manufacturing processes of the Company
*GHG Scope2: Indirect emissions from usage of electricity or heat purchased by the Company
*GHG Scope3: Indirect emissions related to processes other than Scope1 and Scope2 (procurement of raw materials, product shipment, usage, and disposal, employee commuting, business trips, etc.)
1 Eiken Group:Eiken Chemical Co., Ltd. , Eiken China Co., Ltd.
2 Calculated according to Scope 3 items based on the GHG Protocol for items covered by Eiken Group
3 Regular reports based on the Energy Saving Act
4 Waste emissions = general waste emissions + industrial waste emissions
5 Total amount of waste disposal =total emissions - recycled waste (including energy recovery)
Item |
Unit |
FY2017 |
FY2018 |
FY2019 |
FY2020 |
FY2021 |
|
---|---|---|---|---|---|---|---|
Consolidated no. employees |
All employees |
People |
1,016 |
1,040 |
1,053 |
1,087 |
1,119 |
Full-time employees |
People |
704 |
719 |
724 |
733 |
745 | |
Non-consolidated no. employees |
All employees |
People |
961 |
983 |
992 |
1025 |
1,059 |
Full-time employees |
People |
659 |
673 |
677 |
684 |
697 | |
Female employees as share of total |
Full-time employees |
% |
27 |
29 |
29 |
30 |
30 |
No. employees in management 1 |
People |
150 |
150 |
146 |
138 |
131 | |
No. female employees in management 1 |
People |
16 |
18 |
21 |
23 |
22 | |
Female employees in management as share of total |
% |
10.7 |
12.0 |
14.4 |
16.7 |
16.8 | |
No. new hires (new graduates and mid-career) |
People |
48 |
45 |
35 |
40 |
41 | |
No. new hires (new graduates) |
People |
26 |
26 |
19 |
20 |
26 | |
New graduates as share of total new hires |
% |
54 |
58 |
54 |
50 |
63 | |
No. new hires (mid-career) |
People |
22 |
19 |
16 |
20 |
15 | |
Mid-career hires as share of total new hires |
% |
46 |
42 |
46 |
50 |
37 | |
No. female new hires (new graduates and mid-career) |
People |
14 |
16 |
7 |
11 |
12 | |
Female employees as share of new hires |
% |
29 |
36 |
20 |
28 |
29 | |
Disabled persons as share of total employees |
% |
1.62 |
1.84 |
2.35 |
2.60 |
2.41 | |
Turnover (full-time employees) |
Male |
People |
5 |
5 |
12 |
5 |
10 |
Female |
People |
1 |
1 |
2 |
7 |
4 | |
Turnover 2 |
% |
0.9 |
0.9 |
2.0 |
1.7 |
2.0 | |
Avg. no. years continuous service |
Male |
Years |
16yrs. 11mo. |
16yrs. 2mo. |
14yrs. 11mo. |
16yrs. 2mo. |
15yrs. 7mo. |
Female |
Years |
16yrs. .0mo. |
16yrs. 1mo. |
16yrs. 6mo. |
16yrs. 9mo. |
16yrs. 10mo. | |
Avg. no. days of paid leave taken per full-time employee |
Days |
6.0 |
6.7 |
10.4 |
10.6 |
11.4 | |
Rate of uptake of paid leave per full-time employee |
% |
36.6 |
37.8 |
50.3 |
58.0 |
62.1 | |
Total actual work hours per full-time employee per year 3 |
Hours |
2,080 |
2,072 |
1,917 |
1,929 |
1,894 | |
Avg. no. hrs. of overtime work per month |
Hours |
ー |
14.1 |
15.8 |
16.2 |
15.3 | |
Rate of uptake of childcare leave |
Male 4 |
% |
100.0 |
88.9 |
94.5 |
81.8 |
100 |
Female |
% |
100.0 |
100.0 |
83.3 |
100.0 |
67.0 | |
Rate of uptake of stress checks |
% |
97.1 |
97.1 |
98.5 |
98.6 |
98.8 | |
Rate of uptake of regular health checkups |
% |
96 |
100 |
100 |
100 |
99 | |
Rate of uptake of secondary (detailed) clinical tests 5 |
% |
59 |
55 |
58 |
52 |
ー | |
Rate of uptake of harassment prevention training |
% |
ー |
ー |
ー |
84.8 |
100 | |
Number of occupational accidents (incl. traffic accidents) |
Accidents |
4 |
8 |
7 |
8 |
2 | |
Rate of uptake of EGP training among young employees 6 |
% |
ー |
ー |
ー |
16.5 |
14.0 | |
Number of themes in research idea creation activities 7 |
Themes |
ー |
ー |
ー |
10 |
9 |
Consolidated: Eiken Chemical Co., Ltd. and Eiken China Co., Ltd.
Non-consolidated: Eiken Chemical Co., Ltd. (all data other than “Consolidated no. employees” is non-consolidated (Eiken Chemical only))
1 In management: Managerial positions of section-manager level or higher
2 Calculated using: Numerator: No. full-time employees leaving the Company within the fiscal year (April 1 to March 31) , Denominator: No. full-time employees as of April 1 of the fiscal year
3 No. scheduled work hours + no. non-scheduled work hours – annual paid leave and other paid leave
4 Includes persons using the Company’s original leave program for child-rearing
5 Share of employees eligible for detailed clinical tests who undergo such tests at a facility designated by the Health Insurance Society
6 Rate of uptake of the Eiken Global Program: No. Program participants in each fiscal year ÷ no. employees of the fiscal year
7 Includes no. themes continuing from the previous fiscal year
Item |
Unit |
FY2017 |
FY2018 |
FY2019 |
FY2020 |
FY2021 |
|
---|---|---|---|---|---|---|---|
No. directors |
People |
8 |
9 |
9 |
9 |
9 |
|
No. outside directors |
People |
5 |
6 |
6 |
6 |
6 |
|
Outside directors as share of directors |
% |
63 |
67 |
67 |
67 |
67 |
|
No. female directors |
People |
0 |
1 |
1 |
1 |
1 |
|
Female directors as share of directors |
% |
0 |
11 |
11 |
11 |
11 |
|
Board of Directors attendance rate |
% |
98 |
98 |
98 |
100 |
100 |
|
Composition of Nomination Committee |
Inside directors |
People |
1 |
1 |
1 |
1 |
1 |
Outside directors |
People |
2 |
2 |
2 |
2 |
2 |
|
Of whom: Female |
People |
0 |
0 |
0 |
0 |
0 |
|
Composition of Remuneration Committee |
Inside directors |
People |
1 |
1 |
1 |
1 |
1 |
Outside directors |
People |
2 |
2 |
2 |
2 |
2 |
|
Of whom: Female |
People |
0 |
0 |
0 |
0 |
0 |
|
Composition of Audit Committee |
Inside directors |
People |
1 |
0 |
0 |
0 |
0 |
Outside directors |
People |
2 |
3 |
3 |
3 |
3 |
|
Of whom: Female |
People |
0 |
1 |
1 |
1 |
1 |
|
No. executive officers |
People |
11 |
11 |
9 |
10 |
10 |
|
No. female executive officers |
People |
0 |
0 |
0 |
0 |
0 |
|
Female executive officers as share of total |
% |
0 |
0 |
0 |
0 |
0 |
|
Uptake rate of anti-bribery training |
% |
ー |
ー |
ー |
ー |
96.8 |
|
Number of major compliance violations 1 |
|
0 |
0 |
0 |
0 |
0 |
1 Total of major violations in each country of competition law, laws and regulations on bribery and other socioeconomic laws and regulations